logo
This sub-$10 pharma stock is attempting a bullish breakout, according to the charts

This sub-$10 pharma stock is attempting a bullish breakout, according to the charts

CNBC02-07-2025
Healthcare shares performed well on Tuesday, and one notable mover was Viatris (VTRS) . The stock popped up in a routine review of S & P 500 components, where we constantly look for potential basing formations or bullish patterns — whether near highs or attempting to bottom after long periods of underperformance. VTRS clearly falls into the latter category. As we can see, the stock is attempting to break out of two overlapping inverse head-and-shoulders patterns. A decisive move through the $9.50 area would trigger the larger formation, setting up a potential target near $12.30. A logical stop loss would be just below 8.65, near the right shoulder of the smaller pattern and also near the rising 50-day moving average. Now, it's not as if VTRS has sat out the epic market-wide snapback over the past few months—far from it. The stock is already up 38% from its April low, outperforming the S & P 500 and many of its components over that time frame. Still, that recovery pales in comparison to the preceding, nearly 50% decline it suffered from late 2024 through April'25. Looking back at its erratic trading since 2022, a few things stand out. First, the stock has gone through a series of sharp multi-month declines, followed by powerful snapback rallies. And notably, those rallies have consistently produced larger percentage gains than the preceding drawdowns. Another clear takeaway from the chart: in three of the last four rallies, the stock went on to make a higher high relative to the most recent peak. That's the blueprint VTRS bulls will be watching for again now. Thus, if that pattern is to repeat, VTRS likely has more upside ahead. Finally, zooming way out to include price action over the past two decades, it's clear that VTRS remains well below its 2015 highs—but the current comeback is starting to resemble a prior major recovery. In both 2008 and now, 2025, the stock undercut clear multi-year support levels during broad market crashes, only to reverse sharply higher and reclaim those same levels. A few months later in early 2009, the stock went on to break through a steep downtrend line that had been in place for two years. That breakout marked a turning point, triggering an even stronger recovery that extended for several years. Currently, VTRS soon could be confronting an even longer-term downtrend line, drawn from the 2015 peak. From a technical perspective, the next obvious step would be to break above that line. If it can do so —especially while taking advantage of the bullish chart patterns mentioned earlier—then the tide may finally turn. Momentum, which has been negative for years, could shift toward a more constructive path going forward. First step – break out from the small bullish formations. DISCLOSURES: (None) All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. Click here for the full disclaimer.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why AngioDynamics Stock Popped, Then Dropped Today
Why AngioDynamics Stock Popped, Then Dropped Today

Yahoo

time27 minutes ago

  • Yahoo

Why AngioDynamics Stock Popped, Then Dropped Today

AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected adjusted loss, but its GAAP loss was much bigger. AngioDynamics lost money in fiscal 2025 and will probably do that again in 2026. 10 stocks we like better than AngioDynamics › Tuesday started off well for AngioDynamics (NASDAQ: ANGO), maker of such medical devices as the NanoKnife tool for "electrocuting" cancer, as well as multiple devices for treating peripheral vascular disease. In the morning, AngioDynamics reported stronger-than-expected Q4 2025 sales and earnings, with sales of $80.2 million and an adjusted loss of $0.03 per share (instead of the $0.12-per-share forecast). By the end of the day, however, the rally fell completely apart. AngioDynamics ended up closing down almost 10% for the day. So what went wrong? Q4 sales grew 13% year over year, although gross profit margins on those sales declined by 160 basis points, to 52.7%. Adjusted earnings still ended up better than expected, and AngioDynamics cut its loss as calculated according to generally accepted accounting principles (GAAP) by more than half, from $0.33 per share a year ago to just $0.15 per share this time around. Still, a loss is a loss. That's part of the reason investors probably weren't 100% thrilled with this report. For the full-year fiscal 2025, moreover, AngioDynamics lost $0.83 per share according to GAAP, and its sales grew only 8.1%. A second reason is guidance. AngioDynamics told investors it expects fiscal 2026 sales to range from $305 million to $310 million, which is ahead of Wall Street forecasts -- so far, so good. Problem is, management then proceeded to warn its losses for the year will range from $0.25 to $0.35 per share, adjusted for one-time items. That's more than the $0.23 per-share loss Wall Street was forecasting -- and AngioDynamics still hasn't told us how much it will really end up losing under GAAP. Until we know that, the stock probably remains a sell. Before you buy stock in AngioDynamics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and AngioDynamics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $680,559!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,005,670!* Now, it's worth noting Stock Advisor's total average return is 1,053% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why AngioDynamics Stock Popped, Then Dropped Today was originally published by The Motley Fool Sign in to access your portfolio

SPY Attracts $1.8B as S 500 Edges Higher on Tariff Hopes
SPY Attracts $1.8B as S 500 Edges Higher on Tariff Hopes

Yahoo

time30 minutes ago

  • Yahoo

SPY Attracts $1.8B as S 500 Edges Higher on Tariff Hopes

The SPDR S&P 500 ETF Trust (SPY) pulled in $1.8 billion Monday, bringing its assets under management to $641.2 billion, according to data provided by FactSet. The inflows came as the S&P 500 added 0.1% and the Nasdaq Composite rose 0.3% despite President Donald Trump announcing 30% tariffs on the European Union and Mexico over the weekend. The iShares Bitcoin Trust ETF (IBIT) attracted $953.5 million as Bitcoin reached fresh records above $123,000, while the iShares Core MSCI EAFE ETF (IEFA) collected $647.3 million. The iShares Broad USD High Yield Corporate Bond ETF (USHY) gained $371.7 million, and the iShares Core S&P 500 ETF (IVV) pulled in $313.4 million. The Invesco QQQ Trust (QQQ) saw outflows of $1.5 billion, while the iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) lost $432.1 million. The Health Care Select Sector SPDR Fund (XLV) experienced outflows of $351.5 million. U.S. equity ETFs attracted $1.4 billion for the day, while U.S. fixed-income ETFs gained $803.9 million. International equity ETFs pulled in $1.1 billion. Overall, ETFs collected $5.3 billion for the day. Ticker Name Net Flows ($, mm) AUM ($, mm) AUM % Change SPY SPDR S&P 500 ETF Trust 1,777.93 641,229.28 0.28% IBIT iShares Bitcoin Trust ETF 953.52 84,196.73 1.13% IEFA iShares Core MSCI EAFE ETF 647.25 142,694.30 0.45% USHY iShares Broad USD High Yield Corporate Bond ETF 371.73 24,630.90 1.51% IVV iShares Core S&P 500 ETF 313.41 630,958.78 0.05% IWM iShares Russell 2000 ETF 255.10 66,659.08 0.38% SLV iShares Silver Trust 250.41 18,040.07 1.39% AVDV Avantis International Small Cap Value ETF 242.06 10,464.45 2.31% VCSH Vanguard Short-Term Corporate Bond ETF 214.31 34,505.48 0.62% GQGU GQG US Equity ETF 202.11 202.11 100.00% Ticker Name Net Flows ($, mm) AUM ($, mm) AUM % Change QQQ Invesco QQQ Trust Series I -1,524.43 351,838.33 -0.43% LQD iShares iBoxx $ Investment Grade Corporate Bond ETF -432.12 28,725.50 -1.50% XLV Health Care Select Sector SPDR Fund -351.48 33,629.54 -1.05% VB Vanguard Small-Cap ETF -338.86 64,405.89 -0.53% VWOB Vanguard Emerging Markets Government Bond ETF -323.90 4,890.68 -6.62% TLT iShares 20+ Year Treasury Bond ETF -291.45 47,077.40 -0.62% DIA SPDR Dow Jones Industrial Average ETF Trust -177.50 38,204.78 -0.46% SMH VanEck Semiconductor ETF -129.40 27,444.53 -0.47% ARKK ARK Innovation ETF -119.32 6,942.24 -1.72% SOXL Direxion Daily Semiconductor Bull 3x Shares -102.18 14,231.11 -0.72% Net Flows ($, mm) AUM ($, mm) % of AUM Alternatives 2.04 10,229.01 0.02% Asset Allocation 7.97 25,245.31 0.03% Commodities ETFs 492.98 223,765.76 0.22% Currency 1,233.05 171,287.33 0.72% International Equity 1,064.22 1,888,846.27 0.06% International Fixed Income 577.16 306,168.02 0.19% Inverse 100.99 14,181.49 0.71% Leveraged -417.35 145,610.96 -0.29% US Equity 1,387.92 7,215,245.58 0.02% US Fixed Income 803.85 1,702,397.59 0.05% Total: 5,252.83 11,702,977.33 0.04% Disclaimer: All data as of 6 a.m. Eastern time the date the article is published. Data are believed to be accurate; however, transient market data are often subject to subsequent revision and correction by the | © Copyright 2025 All rights reserved

Trading Day: Bond blues mar stocks' joy
Trading Day: Bond blues mar stocks' joy

Yahoo

time31 minutes ago

  • Yahoo

Trading Day: Bond blues mar stocks' joy

ORLANDO, Florida (Reuters) -TRADING DAY Making sense of the forces driving global markets By Jamie McGeever, Markets Columnist The S&P 500 and Nasdaq leaped to new highs on Tuesday thanks to a surge in Nvidia shares, but closed mixed as investors digested a pick-up in U.S. inflation, a raft of major U.S. financial firms' earnings and spiking bond yields around the world, especially in Japan. More on that below, but in my column today I ask whether there is a sense of tariff complacency creeping into markets, as investors increasingly bet on the 'TACO' trade. If you have more time to read, here are a few articles I recommend to help you make sense of what happened in markets today. 1. For Europe, 30% US tariff would hammer trade, forceexport model rethink 2. Trump's fresh Fed attack simmers in markets: Mike Dolan 3. Investors seek protection from risk of Fed chief'souster 4. Fed's inflation fears start to be realized with June CPIincrease 5. What the rest of the world can learn from 'SwissExceptionalism': Jen Today's Key Market Moves * The Nasdaq gains 0.2% but other U.S. indices fall, withthe Russell 2000 small cap index losing 1.7%. Tech is the onlysector on the S&P 500 to rise. * Nvidia shares rise 4% to a new high above $172, pushingits market cap further above the $4 trillion mark. * Britain's FTSE 100 rises above 9000 points for the firsttime ever but ends down 0.6%, its biggest fall sincepost-Liberation Day turmoil in early April. * Japanese Government Bond yields hit fresh highs. The10-year yield is its highest since 2008 at 1.595%, and the 20-and 30-year yields at record peaks of 2.65% and 3.20%,respectively. * The dollar index rises for a seventh session, its best runsince last October. Bond blues mar stocks' joy It was a mixed bag on world markets on Tuesday. Two of Wall Street's three main indices, Britain's FTSE 100 and the MSCI World index hit fresh peaks, yet U.S. inflation rose, bond yields marched higher and investors gave a thumbs down to seemingly solid earnings from U.S. financial firms. Equity market strength was mostly in tech, after AI darling and chipmaker Nvidia said overnight it plans to resume sales of its H20 AI chips to China. Hong Kong's tech index got the ball rolling with a 2.8% rise, and tech was the only sector on the S&P 500 to close in the green. But if the market's glass was half full at the start of the day, it was half empty by the end of it. U.S. inflation was broadly in line with expectations, yet investors focused on the upside risks; U.S. bank earnings were solid, but financials were among the biggest decliners. The shadow of higher bond yields is beginning to lengthen as worries over governments' fiscal health, tariff-driven inflation and investor appetite for fixed income assets pick up again. The 30-year U.S. Treasury yield is back above 5.00%, but the eye of the bond market hurricane appears to be in Japan. Investor angst around an Upper House election on Sunday is bubbling up. Prime Minister Shigeru Ishiba's sliding popularity suggests even his modest goal of retaining a majority is out of reach, and defeat could bring anything from a shift in the makeup of Ishiba's coalition to his resignation. Japanese government bond yields are surging, but that's proving to be a headwind for the yen rather than a tailwind as extra pressure on the country's already strained public finances, a straight-jacketed Bank of Japan and stagflation fears more than offset any potential carry for yen investors. The yen slumped to a three-month low on Tuesday, back within sight of the 150 per dollar mark. The raft of economic indicators from China overnight, meanwhile, generally showed activity in June held up better than economists expected, and second quarter GDP growth was slightly stronger than forecasts too. But Beijing is still under pressure to inject more stimulus into the economy. The property bubble continues to deflate, with new home prices falling at their fastest pace in eight months, and more broadly, China's economic surprises index is its lowest in three months. If incoming data is beating forecasts, it is because expectations have been lowered so much. Tariff 'doom loop' hangs over global equities The astonishing rebound in stocks since early April largely reflects investors' bet that U.S. President Donald Trump won't follow through on his tariff threats. But the market's very resilience may encourage the president to push forward, which could be bad news for equities in both the U.S. and Europe. Investors appear to believe that the April 2 "reciprocal" tariffs were mostly a tactic to bring countries to the negotiating table, and Washington's levies will end up being much lower than advertised. Tariffs may end up much higher than they were before Trump's second term began, but the situation will still be better than the worst-case scenarios initially priced in after Trump's so-called "Liberation Day". Monday's equity moves were a case in point. Trump's threat on Saturday to impose 30% levies on imports from the European Union and Mexico - two of America's largest trading partners - was met with a collective market shrug. European and Mexican stocks dipped a bit, but Wall Street closed in the green and the Nasdaq hit a new high. This follows threats in recent days to place a 50% tariff rate on goods imported from Brazil and a 35% levy on goods from Canada not covered under the USMCA agreement. Brazilian stocks have slipped 5%, but Canadian stocks have hit new peaks. The question now is whether the line between complacency and the "TACO" trade - the bet that "Trump always chickens out" - is getting blurred. GETTING STRETCHED The scale of the recovery since April 7 is truly eye-popping. It took the S&P 500 less than three months to move from the April bear market lows to a new all-time high, as Charlie Bilello, chief market strategist at Creative Planning, recently noted on X. This was the second-fastest recovery in the last 75 years, only bested by the bear market recovery in 1982 that took less than two months. On a 12-month forward earnings basis, the S&P 500 index is now near its highest level in years and well above its long-term average. The tech sector, which has propelled the rally, has rarely been more expensive in the last quarter century either. None of that means further gains cannot materialize, and one could argue that the valuations are justified if AI truly delivers the promised world-changing productivity gains. Regardless, it is hard to argue that the rally since April is not rooted in the belief that tariffs will be significantly lower than the levels announced on Liberation Day. If many countries' levies do end up around 10% like Britain's and the aggregate rate settles around 15%, then equity pricing might very well be reasonable. But if that's not the case, growth forecasts will likely have to be revised a lot lower. "We stay overweight U.S. stocks, but don't rule out more sharp near-term market moves. Uncertainty on who will bear tariff costs means yet more dispersion in returns – and more opportunity to earn alpha, or above-benchmark returns," BlackRock Investment Institute analysts wrote on Monday. DOOM LOOP? One concern is that a loop is potentially being created, whereby Wall Street's resilience and strength in the face of heightened trade uncertainty actually emboldens Trump to double down on tariffs. Most analysts still believe cooler heads will prevail, however. Trump's tolerance for equity and bond market stress, and therefore U.S. economic pain, appears "limited", according to Barclays. But if markets have gotten too complacent and Trump does increase tariffs on EU goods to 30%, potential retaliation would risk a repeat of something similar to the post-Liberation Day selloff, sending European equities down by double digits, Barclays warns. It may also be that when it comes to tariffs, investors are focusing so intently on China that not much else moves the dial. This may be short-sighted though. China accounted for 13.4% of U.S. goods imports last year, the lowest in 20 years. In contrast, the U.S. imported $605.7 billion of goods from the European Union, or 18.6% of all imports and the most from any single jurisdiction. As Trump sees it, Europe is "ripping off" America almost as much as China. Bilateral U.S.-China trade last year totaled $582 billion, compared with bilateral U.S.-EU trade flows of $975 billion, U.S. Census data shows. America's $235.9 billion goods deficit with the EU was smaller than its $295.5 billion gaps with China, but that's still comfortably America's second-biggest trade deficit. What could move markets tomorrow? * Japan non-manufacturing tankan survey (July) * Indonesia interest rate decision * UK CPI inflation (June) * U.S. corporate earnings including financial heavyweightsMorgan Stanley, Goldman Sachs, and Bank of America * U.S. PPI inflation (June) * U.S. industrial production (June) * U.S. Fed officials scheduled to speak: Governor MichaelBarr, Cleveland Fed President Beth Hammack, Richmond FedPresident Thomas Barkin, New York Fed President John Williams Want to receive Trading Day in your inbox every weekday morning? Sign up for my newsletter here. Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias. (By Jamie McGeever)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store